• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Second- and Third-Line Pharmacotherapy for Type 2 Diabetes: Update [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Jul. (CADTH Optimal Use Report, No. 3.1.)

Cover of Second- and Third-Line Pharmacotherapy for Type 2 Diabetes: Update

Second- and Third-Line Pharmacotherapy for Type 2 Diabetes: Update [Internet].

Show details

APPENDIX 6SERIOUS ADVERSE EVENTS IN INCLUDED TRIALS (ORIGINAL REVIEW AND UPDATE)

Table 17. Summary of Serious Adverse Events in Second-Line RCTs.

Table 17

Summary of Serious Adverse Events in Second-Line RCTs.

Copyright © CADTH 2013.
Bookshelf ID: NBK169678
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...